Items where Subject is "Australian and New Zealand Standard Research Classification > MEDICAL AND HEALTH SCIENCES (110000) > ONCOLOGY AND CARCINOGENESIS (111200) > Molecular Targets (111207)"
|Up a level|
- Subjects classification (42113)
- Australian and New Zealand Standard Research Classification (42113)
Group by: Authors/Creators | Item Type
Number of items at this level: 16.
Jingjing, You, Cozzi, Paul, Fitzgerald , Anna, Walsh, Bradley, Russell, Pamela J., Willcox, Mark, et al. (2012) Prostate cancer biomarkers and the emerging proteomic techniques used in biomarker research. In Watanabe, Hiroto S. (Ed.) Horizons in Cancer Research : Volume 47. Nova Science Publishers Inc, New York, pp. 1-36.
Byron, Sara A., Gartside, Michael, Powell, Matthew A., Wellens, Candice L., Gao, Feng, Mutch, David G., et al. (2012) FGFR2 point mutations in 466 Endometrioid Endometrial Tumors : relationship with MSI, KRAS, PIK3CA, CTNNB1 mutations and Clinicopathological features. PLoS ONE, 7(2), e30801-e30801.
Byron, Sara A., Loch, David, & Pollock, Pamela M. (2012) Fibroblast growth factor receptor inhibition synergizes with paclitaxel and doxorubicin in endometrial cancer cells. International Journal of Gynecological Cancer, 22(9), pp. 1517-1526.
Byron, Sara A., Loch, David C. , Wellens, Candice L., Wortmann, Andreas, Wu, Jiayi, Wang, John, et al. (2012) Sensitivity to the MEK inhibitor E6201 in melanoma cells is associated with mutant BRAF and wildtype PTEN status. BMC Molecular Cancer, 11(75).
Chopin, L. K., Seim, I., Walpole, C. M., & Herington, A. C. (2012) The Ghrelin axis : does it have an appetite for cancer progression? Endocrine Reviews, 33(6), pp. 849-891.
Dong, Ying, Batra, Jyotsna, Anand, Kamal, Bapat, Sharmila, & Clements, Judith A. (2014) Transforming the future of treatment for ovarian cancer. Clinical & Experimental Pharmacology, 4(3), p. 1000157.
Dutton-Regester, Ken & Hayward, Nicholas K. (2012) Whole genome and exome sequencing of melanoma. Advances in Pharmacology, 65, pp. 399-435.
Dutton-Regester, Ken, Irwin, Darryl, Hunt, Priscilla, Aoude, Lauren G., Tembe, Varsha, Pupo, Gulietta M., et al. (2012) A high-throughput panel for identifying clinically relevant mutation profiles in melanoma. Molecular Cancer Therapeutics, 11(4), pp. 888-897.
Krauthammer, Michael, Kong, Yong, Ha, Byung Hak, Evans, Perry, Bacchiocchi, Antonella, McCusker, James P, et al. (2012) Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nature Genetics, 44(9), pp. 1006-1014.
Libério, Michelle S., Sadowski, Martin, Nelson, Colleen C., & Davis, Rohan A. (2014) Identification of eusynstyelamide B as a potent cell cycle inhibitor following the generation and screening of an ascidian-derived extract library using a real time cell analyzer. Marine Drugs, 12(10), pp. 5222-5239.
Lisle, Jessica E., Mertens-Walker, Inga, Rutkowski, Raphael, Herington, Adrian C., & Stephenson, Sally-Anne (2013) Eph receptors and their ligands : promising molecular biomarkers and therapeutic targets in prostate cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1835(2), pp. 243-257.
Loch, David & Pollock, Pamela M. (2012) Lineage-specific biomarkers predict response to FGFR inhibition. Cancer Discovery, 2, pp. 1081-1083.
Maddaluno, Luigi, Verbrugge, Sue Ellen, Martinoli, Chiara, Matteoli, Gianluca, Chiavelli, Andrea, Zeng, Yiping, et al. (2009) The adhesion molecule L1 regulates transendothelial migration and trafficking of dendritic cells. Journal of Experimental Medicine, 206(3), pp. 623-635.
Moore, Nicole L., Buchanan, Grant, Harris, Jonathan M., Selth, Luke A., Bianco-Miotto, Tina, Hanson, Adrienne R., et al. (2012) An androgen receptor mutation in the MDA-MB-453 cell line model of molecular apocrine breast cancer compromises receptor activity. Endocrine Related Cancer, 19(4), pp. 599-613.
Rutowski, Raphael, Mertens-Walker, Inga, Lisle, Jessica E, Herington, Adrian C., & Stephenson, Sally-Anne (2012) Evidence for a dual function of EphB4 as tumor promoter and suppressor regulated by the absence or presence of the ephrin-B2 ligand. International Journal of Cancer, 131(5), E614-E624.
Tse, B.W.C., Cowin, G.J., Soekmadji, C., Jovanovic, L., Vasireddy, R, Ling, M.T., et al. (2014) Enhancing MRI of prostate cancer using PSMA-targeting iron oxide magnetic nanoparticles. In 67th Annual Scientific Meeting of the Urological Society of Australia and New Zealand (USANZ 2014), 16–19 March 2014, Brisbane, QLD.